Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: Brain Pathol. 2017 Jan 19;28(2):274–283. doi: 10.1111/bpa.12482

Table 1.

Summary of clinicopathological data

Case-1 Case-2 Case-3
Age at death (years) 83 72 91
Sex male female female
Duration of illness (years) 20 5 20
Clinical diagnosis PSP+ MCI PSP+dementia Unclassified dementia
Symptoms at early stage Imbalance and gait
disorder
Incoordination Not available
Symptoms at late stage Cognitive decline Cognitive decline Cognitive decline
Supranuclear gaze
palsy
Supranuclear gaze
palsy
2 grand mal seizures Parkinsonism
Motor-Dementia interval 15 years 0 years 0 years
  Family history no no yes
  ApoE E2/E3 E3/E3 E2/E3
  H1/H2 haplotype H1/H1 H1/H1 H2/H2
  MAPT mutation none none none
  Brain weight 1378 1147 1066
  ABC score A0B2C0 A1B1C0 A3B3C3
  pTDP-43 no no yes
  α-synuclein no no no
  Hippocampal sclerosis no yes yes
  Other - Focal encephalitis in
brainstem
Lacunar infarcts in
Globus pallidus and
brainstem
-

ABC score indicates the score provide for Aβ deposition (A), for Braak stage of neurofibrillary degeneration (B), and neuritic plaque score (C)(28).

PSP: progressive supranuclear palsy; MCI: mild cognitive impairment.